Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis.

MLA

Vincent, Jean-Louis, et al. “Use of an Integrated Clinical Trial Database to Evaluate the Effect of Timing of Drotrecogin Alfa (Activated) Treatment in Severe Sepsis.” Critical Care (London, England), vol. 10, no. 3, 2006, p. R74. EBSCOhost, https://doi.org/10.1186/cc4909.

APA

Vincent, J.-L., O’Brien, J., Jr, Wheeler, A., Wittebole, X., Garg, R., Trzaskoma, B. L., & Sundin, D. P. (2006). Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis. Critical Care (London, England), 10(3), R74. https://doi.org/10.1186/cc4909

Chicago

Vincent, Jean-Louis, James O’Brien Jr, Arthur Wheeler, Xavier Wittebole, Rekha Garg, Benjamin L Trzaskoma, and David P Sundin. 2006. “Use of an Integrated Clinical Trial Database to Evaluate the Effect of Timing of Drotrecogin Alfa (Activated) Treatment in Severe Sepsis.” Critical Care (London, England) 10 (3): R74. doi:10.1186/cc4909.